FDA PCAC reviews 7 peptides in July. Read →

PeptideXpo

P21 (P021)

CNTF-derived neurogenic tetrapeptide with adamantane moiety

≥ 99.0%CAS (verification pending — please confirm via COA)Cognitive & Neuropeptides

Overview

P21 (P021) is a CNTF-derived synthetic tetrapeptide (core: DGGL, with adamantane attachment) studied for neurogenesis, BDNF expression, and cognitive research.

Specifications

CAS
(verification pending — please confirm via COA)
Sequence
DGGL (adamantylated)
Purity (HPLC)
≥ 99.0%
Common vial sizes
5 mg
MOQ
On request
Lead time
14–21 days
Storage
-20°C, protect from light

Documentation available on request

  • Certificate of Analysis (COA)
  • HPLC Chromatogram
  • Mass-spec spectrum
  • Stability data
  • SDS / MSDS
  • Sequence verification

Regulatory note

Research peptide derivative; CAS is not consistently registered. Sold for research use only.